BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15117317)

  • 1. Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation.
    Kiachopoulos S; Heske J; Tatzelt J; Winklhofer KF
    Traffic; 2004 Jun; 5(6):426-36. PubMed ID: 15117317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocatalytic self-propagation of misfolded prion protein.
    Bieschke J; Weber P; Sarafoff N; Beekes M; Giese A; Kretzschmar H
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12207-11. PubMed ID: 15297610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper induces conformational changes in the N-terminal part of cell-surface PrPC.
    Leclerc E; Serban H; Prusiner SB; Burton DR; Williamson RA
    Arch Virol; 2006 Nov; 151(11):2103-9. PubMed ID: 16791441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
    Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
    J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
    Pimpinelli F; Lehmann S; Maridonneau-Parini I
    Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis.
    Sunyach C; Checler F
    J Neurochem; 2005 Mar; 92(6):1399-407. PubMed ID: 15748158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
    Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis.
    Taylor DR; Watt NT; Perera WS; Hooper NM
    J Cell Sci; 2005 Nov; 118(Pt 21):5141-53. PubMed ID: 16254249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
    Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
    Biophys J; 2001 Jul; 81(1):516-25. PubMed ID: 11423433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of lumenal prion protein aggregates by post-ER quality control mechanisms is mediated by the preoctarepeat region of PrP.
    Gilch S; Nunziante M; Ertmer A; Wopfner F; Laszlo L; Schätzl HM
    Traffic; 2004 Apr; 5(4):300-13. PubMed ID: 15030571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.